Detalles de la búsqueda
1.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Breast Cancer Res Treat
; 203(3): 497-509, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938495
2.
Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet
; 397(10271): 281-292, 2021 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485453
3.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727538
4.
A preliminary trial examining a 'real world' approach for increasing physical activity among breast cancer survivors: findings from project MOVE.
BMC Cancer
; 19(1): 272, 2019 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917793
5.
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
Invest New Drugs
; 36(2): 278-287, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29250742
6.
Acceptability and satisfaction of project MOVE: A pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivors.
Psychooncology
; 27(4): 1251-1256, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409128
7.
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
Breast Cancer Res
; 19(1): 54, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464908
8.
Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
Oncologist
; 21(2): 141-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26764251
9.
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Breast Cancer Res Treat
; 157(1): 109-16, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116183
10.
Abiraterone and increased survival in metastatic prostate cancer.
N Engl J Med
; 364(21): 1995-2005, 2011 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21612468
11.
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.
Invest New Drugs
; 32(4): 746-52, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24671507
12.
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer.
Invest New Drugs
; 30(4): 1652-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21785998
13.
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.
Cancer Med
; 11(2): 332-339, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921525
14.
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.
Clin Cancer Res
; 27(20): 5482-5491, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301749
15.
Utilizing RE-AIM to examine the translational potential of Project MOVE, a novel intervention for increasing physical activity levels in breast cancer survivors.
Transl Behav Med
; 9(4): 646-655, 2019 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060250
16.
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.
Clin Genitourin Cancer
; 17(3): 201-208.e1, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31056399
17.
Innovative approach for increasing physical activity among breast cancer survivors: protocol for Project MOVE, a quasi-experimental study.
BMJ Open
; 6(8): e012533, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27531738
18.
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.
J Clin Oncol
; 33(14): 1574-83, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25779558
19.
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.
J Clin Oncol
; 32(14): 1427-36, 2014 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711552
20.
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
PLoS One
; 6(7): e21121, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21754983